Alfafarmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-05-20
Share capital
50,000.00 PLN
Registered address
ul. Łąkowa 7A/D12, 90-562 Łódź, Poland
Phone
Electronic delivery address
AE:PL-31125-79686-HAWRE-15

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 91 days for 2021).

  • 202514/07/2026
  • 202411/07/2025
  • 202311/07/2024
  • 202220/07/2023
  • 202114/10/2022
  • 202014/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 787.03kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD -20.75kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 801.08kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 156.34kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Katarzyna Anna Sorbian – Attorney-in-fact (sole)
Jean Philippe Debeaudoin – President of the Management Board
Małgorzata Elżbieta Skab – Attorney-in-fact (sole)

Manner of representation

In the case of a multi-member management board, each member of the management board is authorized to make declarations of will on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Jean Philippe Debeaudoin
410$11,075.0982%
Others
90$2,431.1218%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2004-12-31.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,183
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,183

Competitors

Name
Bechtold & Cosp. z o.o.
Sis-Medsp. z o.o.
TDFS.A.
Mercantsp. z o.o.
Rhinegene Polandsp. z o.o.
Mediationsp. z o.o.
Goldfarmexsp. z o.o.
Orthoactivesp. z o.o.
CanpolandS.A.
Geneco Groupsp. z o.o.

Change history

DateEvent
2023-11-10Address change
2015-07-15Address change
2015-07-15PKD change
2014-03-06Switch to PKD 2007
2004-05-20Entered in the register

FAQ

Last updated: 2026-07-17